| Nov 4 |
Adverum Biotechnologies (ADVM) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 4 |
Adverum Biotechnologies GAAP EPS of -$1.30 beats by $0.01
|
| Nov 4 |
Adverum Biotechnologies: Q3 Earnings Snapshot
|
| Nov 4 |
Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones
|
| Oct 16 |
Adverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer as it Prepares to Initiate Pivotal Program
|
| Oct 11 |
Adverum Biotechnologies (ADVM) Upgraded to Strong Buy: What Does It Mean for the Stock?
|
| Oct 3 |
Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic
|
| Sep 5 |
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Sep 4 |
Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences
|
| Sep 3 |
Wall Street Analysts See a 332.28% Upside in Adverum Biotechnologies (ADVM): Can the Stock Really Move This High?
|
